AngioDynamics, Inc. (ANGO) vs Anbio Biotechnology (NNNN)

AngioDynamics, Inc. and Anbio Biotechnology are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $884.9M against $631.6M — 1.4× the size. Across the 8 metrics below, Anbio Biotechnology leads on 7 and AngioDynamics, Inc. on 1.

Valuation

Metric ANGO NNNN Medical Instruments & Supplies median
P/E n/m — 34.17
P/S 2.01 — 2.83
P/B 3.77 n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 2.01 n/m 3.06
Earnings yield (5.62%) — (1.84%)
Free cash flow yield (0.51%) 0.00% 0.17%

Profitability

Metric ANGO NNNN Medical Instruments & Supplies median
Gross margin 54.62% — 54.62%
Operating margin (12.47%) — 1.64%
Net margin (11.48%) — 0.00%
Free cash flow margin 0.16% 0.00% 1.61%
Return on equity (20.77%) 0.00% 0.00%
Return on assets (13.43%) 0.00% 0.00%
Return on invested capital (21.34%) 0.00% 0.00%

Growth

Metric ANGO NNNN Medical Instruments & Supplies median
Revenue growth (TTM) 9.46% — 9.20%
EPS growth (last fiscal year) (6.02%) 150.00% —
Revenue growth, 5-year CAGR 1.93% — 9.48%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ANGO NNNN Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 2.19 344.45 2.49
Net debt to EBITDA 3.17 (2.06) 0.83

Dividend

Metric ANGO NNNN Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 — 0.00

Size

Metric ANGO NNNN Medical Instruments & Supplies median
Market cap 631.56m 884.93m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack